Case Study: NICE achieves breakthrough UK media coverage for metastatic breast cancer with JPA Health

NICE achieves 146 media placements with JPA Health

The customer, NICE, faced the challenge of communicating a complex medication approval for metastatic breast cancer within a highly regulated UK media market. Their goal was to convey accurate scientific information in an understandable way to healthcare professionals, patients, and the public. JPA Health was engaged to execute an earned media strategy to navigate this intricate landscape.

JPA Health's solution was to provide journalists with embargoed access to the news alongside access to a key opinion leader and a patient. This approach provided crucial context about the medication's real-life benefits. The strategy implemented by JPA Health resulted in 146 media placements, over 573 million potential impressions, and more than 100 social posts, exceeding all client expectations for both the quantity and quality of coverage.

NICE